VCBeat (WeChat ID: vcbeat) has learned thatOn July 17, JD.com announced new personnel appointments: Xu Lei, Rotating CEO of JD Retail Group, was appointed Chairman of JD Health; Xin Lijun, Vice President of JD.com and President of the Life Services Business Group under JD Retail, was appointed CEO of JD Health.
Xin Lijun joined JD.com in October 2012 and has served as General Manager of the Home Furnishing and Decoration Department under JD Mall’s Open Platform, as well as President of the Home and Lifestyle Business Unit of JD Mall. While serving as CEO of JD Health, Xin Lijun will continue to hold the position of President of the Life Services Business Group within JD Retail Group.
JD Health officially announced its independent operations on May 10, 2019. Leveraging the capabilities and resource advantages of JD.com, JD Health will gradually refine its “Internet + Healthcare” industrial layout, building upon its four existing business segments—pharmaceutical and health e-commerce, internet healthcare, health services, and smart solutions—to become a flagship enterprise in the health industry.
Specifically:
In the e-commerce sector for pharmaceuticals and healthcare, JD Health currently operates businesses including retail pharmacy, pharmaceutical wholesale, and the retail of non-pharmaceutical general health products.
The Internet Healthcare segment primarily focuses on patient needs by providing medical services such as online appointment registration and online consultations. Leveraging JD.com’s unique pharmaceutical supply chain advantages, it pioneered the industry’s first closed-loop “Medical + Pharmaceutical” model online.
The Health Services section provides users with consumer healthcare services, including physical examinations, medical aesthetics, dental care, genetic testing, and vaccine appointments.
The “Smart Solutions” section primarily serves offline physical pharmacies, hospitals, government agencies, and other partners by providing them with smart solutions based on Internet Plus technology.
Among the aforementioned business segments, JD Health has successfully established core products and sub-brands such as JD Pharmacy, Yaojingcai, and JD Internet Hospital. Notably, after more than three years of development, JD Pharmacy has become one of the largest retail pharmacies integrating online and offline operations, with a product portfolio covering over-the-counter (OTC) drugs, medical devices, health supplements, nutritional tonics, family planning products, and other general health-related commodities.
Yaojingcai, a third-party pharmaceutical wholesale trading platform, has maintained rapid growth since its launch. As of July 2019, it had covered 19 provincial-level administrative regions and 47 cities across China, serving nearly 100,000 downstream purchasing merchants, making it one of the largest third-party pharmaceutical wholesale platforms in China.
JD Internet Hospital is one of the first internet hospitals in China to obtain a "Medical Institution Practice License." The platform’s physicians hail from 327 cities across 32 provincial-level administrative divisions in China, with 60% coming from Grade A tertiary hospitals and 78% holding attending physician titles or higher. Furthermore, JD Health is collaborating with multiple renowned medical institutions to explore informatized and intelligent healthcare solutions.
As a subsidiary group under JD.com focused on operating businesses related to general health, JD Health’s products and services have initially achieved coverage across the entire pharmaceutical industry chain, the full medical care process, all health scenarios, and the entire user life cycle, thereby building the most extensive and complete “Internet + Healthcare” ecosystem in the industry.
JD Health secured over $1 billion in Series A financing in early May this year, becoming the third “mega-unicorn” cultivated by JD.com Group, following JD Digits and JD Logistics.
VCBeat previously reported:
JD Health: How Is JD.com’s Third Unicorn Flexing Its Muscle in Healthcare?